Figure 1. A 111In-octreotide SPECT/CT in Case 3 patient, as baseline before sunitinib treatment. The patient have a focus of markedly increased receptor density in the left tuber ischiadicum, showing relaps of disease after eight years remission.
Figure 2. A 111In-octreoitide SPECT/CT in Case 3 patient, after two courses of sunitinib treatment, showing clear regression of 111In-octreoitide uptake in osseous lesion, and corresponding to PR of disease.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.